Page last updated: 2024-12-05

allobarbital

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

allobarbital: was heading 1976-94 (see under BARBITURATES 1976-90); ALLOBARBITONE, DIALLYLBARBITAL, DIALLYLBARBITURIC ACID, & DIALLYLMAL were see ALLOBARBITAL 1976-94; use BARBITURATES to search ALLOBARBITAL 1976-94; a barbiturate derivative with effects of intermediate duration; at lower doses, it is used as a sedative; at higher doses, it displays hypnotic effects [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5842
CHEMBL ID267719
CHEBI ID134875
SCHEMBL ID35976
SCHEMBL ID15364694
MeSH IDM0225316

Synonyms (77)

Synonym
2,4,6(1h,3h,5h)-pyrimidinetrione, 5,5-di-2-propenyl-
barbituric acid, 5,5-diallyl-
5,5-diprop-2-en-1-ylpyrimidine-2,4,6(1h,3h,5h)-trione
allobarbital (usan/inn)
D02817
allbarbital
barballyl
dorm
barbituric acid,5-diallyl-
2,6(1h,3h,5h)-pyrimidinetrione, 5,5-di-2-propenyl-
allylbarbitural
curral
5,5-diallylbarbituric acid
allobarbitone
diadol
dormallyl
diallylbarbital
nsc-9324
alobarbital
52-43-7
novallyl
dialog
malil
malilum
wln: t6vmvmv fhj f2u1 f2u1
dial (barbiturate)
alnox
diallylbarbiturate
allobarbital
diallymal
nsc9324
5,5-diallyl-barbituric acid
diallylbarbituric acid
barbidal
allobarbitale [dcit]
5,5-di-2-propenyl-2,4,6(1h,3h,5h)-pyrimidinetrione
5,5-diallylbarbitursaeure
diallymalum
ai3-02725
nsc 9324
ccris 7087
go 1058
einecs 200-140-4
allobarbitalum [inn-latin]
allobarbital [usan:inn]
inchi=1/c10h12n2o3/c1-3-5-10(6-4-2)7(13)11-9(15)12-8(10)14/h3-4h,1-2,5-6h2,(h2,11,12,13,14,15
CHEBI:134875
CHEMBL267719
5,5-bis(prop-2-enyl)-1,3-diazinane-2,4,6-trione
unii-8nt43gg2ha
allobarbitalum
8nt43gg2ha ,
allobarbitale
A829085
A0739
SCHEMBL35976
allobarbital [inn]
allobarbital [mart.]
allobarbital [mi]
allobarbital [usan]
allobarbital [who-dd]
allybarbitural
5,5-diallyl-2,4,6(1h,3h,5h)-pyrimidinetrione #
component of dialog (salt/mix)
SCHEMBL15364694
DTXSID9022572
2-hydroxy-5,5-di(prop-2-en-1-yl)pyrimidine-4,6(1h,5h)-dione
STL453798
allobarbital; 5,5-diallybarbituric acid; 5,5-di-2-propenyl-2,4,6(1h,3h,5h)pyrimidinetrione; allobarbitone; dial
allobarbital 0.1 mg/ml in methanol
allobarbital 1.0 mg/ml in methanol
allobarbital reg# - -
Q418905
5,5-diallylbarbitursa currencyure
DB13577
2,4,6(1h,3h,5h)-pyrimidinetrione, 5,5-di-2-propen-1-yl-
allobarbital, 1mg/ml in methanol
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
barbituratesMembers of the class of pyrimidones consisting of pyrimidine-2,4,6(1H,3H,5H)-trione (barbituric acid) and its derivatives. Largest group of the synthetic sedative/hypnotics, sharing a characteristic six-membered ring structure.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (16)

Assay IDTitleYearJournalArticle
AID1130943Octanol-water partition coefficient, log P of nonionized form of compound1979Journal of medicinal chemistry, Nov, Volume: 22, Issue:11
Correlation of biological activity and high-pressure liquid chromatographic retention index for a series of propranolol, barbiturate, and anthranilic acid analogues.
AID26320pKa value is evaluated1983Journal of medicinal chemistry, Jul, Volume: 26, Issue:7
A simplified high-pressure liquid chromatography method for determining lipophilicity for structure-activity relationships.
AID167610Negative log of minimum effective dose (moles per kilogram) in rabbits (hypnotic)1983Journal of medicinal chemistry, Jul, Volume: 26, Issue:7
A simplified high-pressure liquid chromatography method for determining lipophilicity for structure-activity relationships.
AID588211Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
AID1130940Retention index of the compound by HPLC method1979Journal of medicinal chemistry, Nov, Volume: 22, Issue:11
Correlation of biological activity and high-pressure liquid chromatographic retention index for a series of propranolol, barbiturate, and anthranilic acid analogues.
AID588212Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
AID38914Negative log of molar concentration (-log ED50) required to reduce cell division by 50% in Arbacia egg1983Journal of medicinal chemistry, Jul, Volume: 26, Issue:7
A simplified high-pressure liquid chromatography method for determining lipophilicity for structure-activity relationships.
AID409957Inhibition of bovine liver MAOA2008Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
AID1130945Inhibition of Arbacia egg cell division1979Journal of medicinal chemistry, Nov, Volume: 22, Issue:11
Correlation of biological activity and high-pressure liquid chromatographic retention index for a series of propranolol, barbiturate, and anthranilic acid analogues.
AID1130944Hypnotic activity in rabbit1979Journal of medicinal chemistry, Nov, Volume: 22, Issue:11
Correlation of biological activity and high-pressure liquid chromatographic retention index for a series of propranolol, barbiturate, and anthranilic acid analogues.
AID588213Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
AID346025Binding affinity to beta cyclodextrin2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Convenient QSAR model for predicting the complexation of structurally diverse compounds with beta-cyclodextrins.
AID1145374Induction of hypnotic activity in rat1976Journal of medicinal chemistry, May, Volume: 19, Issue:5
Molecular connectivity. 6. Examination of the parabolic relationship between molecular connectivity and biological activity.
AID409959Inhibition of bovine liver MAOB2008Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
AID24211Compound is evaluated for ionization constant log k1983Journal of medicinal chemistry, Jul, Volume: 26, Issue:7
A simplified high-pressure liquid chromatography method for determining lipophilicity for structure-activity relationships.
AID169098Negative log of molar concentration (-log C) required to produce 50% inhibition of oxygen (oxygen uptake) on rat brain respiration in vitro; ND = No Data1983Journal of medicinal chemistry, Jul, Volume: 26, Issue:7
A simplified high-pressure liquid chromatography method for determining lipophilicity for structure-activity relationships.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (17)

TimeframeStudies, This Drug (%)All Drugs %
pre-199010 (58.82)18.7374
1990's2 (11.76)18.2507
2000's4 (23.53)29.6817
2010's1 (5.88)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 36.63

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index36.63 (24.57)
Research Supply Index2.89 (2.92)
Research Growth Index4.28 (4.65)
Search Engine Demand Index50.49 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (36.63)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other17 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]